So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
All content for EnRitched Menopause is the property of Jessica Ritch, MD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
Have you ever started hormone replacement therapy (HRT) and noticed unexpected bleeding? It can feel confusing - or even alarming. In this episode, I open up a conversation many women are hesitant to have: abnormal bleeding while on HRT. Whether you're new to therapy or have been on it for a while, understanding what's considered normal versus what’s worth checking out is key to managing your health confidently. I’ll walk you through the most common causes, when to seek help, and what y...
EnRitched Menopause
So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
